Response to Zhang and Ho: Addressing Ketamine's Use in Depression

Affiliations

¹ From the Departments of Obstetrics and Gynecology and of Psychiatry and Behavioral Sciences, and the Center on Aging, University of Miami Miller School of Medicine, Miami.

Comment

D Jeffrey Newport et al. Am J Psychiatry. 2016.

. 2016 Apr 1;173(4):431-2.

doi: 10.1176/appi.ajp.2016.15111401r.

¹ From the Departments of Obstetrics and Gynecology and of Psychiatry and Behavioral Sciences, and the Center on Aging, University of Miami Miller School of Medicine, Miami.

No abstract available

Comment on

Ketamine and Other NMDA Antagonists: Early Clinical Trials and Possible Mechanisms in Depression.
Newport DJ, Carpenter LL, McDonald WM, Potash JB, Tohen M, Nemeroff CB; APA Council of Research Task Force on Novel Biomarkers and Treatments. Newport DJ, et al. Am J Psychiatry. 2015 Oct;172(10):950-66. doi: 10.1176/appi.ajp.2015.15040465. Am J Psychiatry. 2015. PMID: 26423481
Critical Appraisal of Existing Ketamine Trials: Existing Limitations and Limited Applicability for Treatment.
Zhang MW, Ho R. Zhang MW, et al. Am J Psychiatry. 2016 Apr 1;173(4):431. doi: 10.1176/appi.ajp.2016.15111401. Am J Psychiatry. 2016. PMID: 27035535 No abstract available.